Treating carbapenemase-producing Enterobacterales urosepsis with ceftazidime/avibactam in pregnancy

被引：2
|
作者：
Broderick, Claire [1 ,4 ]
Lebedevs, Tamara [1 ]
Hazelton, Briony [2 ,3 ]
机构：
[1] King Edward Mem Hosp, Subiaco, WA, Australia
[2] Perth Childrens Hosp, Dept Infect Dis, Nedlands, WA, Australia
[3] QEII Med Ctr, Dept Microbiol, PathWest Lab Med, PP Block, Nedlands, WA, Australia
[4] King Edward Mem Hosp, Dept Pharm, 374 Bagot Rd, Subiaco, WA 6008, Australia
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2023年 / 62卷 / 03期
关键词：
D O I：
10.1016/j.ijantimicag.2023.106903
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae
    Zhang, Wenxia
    Guo, Yan
    Li, Jiayin
    Zhang, Yiyuan
    Yang, Yang
    Dong, Dong
    Zhu, Demei
    He, Ping
    Hu, Fupin
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
  • [22] The seasonality of carbapenemase-producing Enterobacterales in South Korea
    Kim, J. Y.
    Park, S.
    Kim, E. O.
    Chang, E.
    Bae, S.
    Kim, M. J.
    Chong, Y. P.
    Choi, S-H.
    Lee, S-O.
    Kim, Y. S.
    Jung, J.
    Kim, S-H.
    JOURNAL OF HOSPITAL INFECTION, 2023, 140 : 87 - 89
  • [23] Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae
    O. Lima
    A. Sousa
    R. Longueira-Suárez
    A. Filgueira
    C. Taboada-Martínez
    C. Portela-Pino
    A. Nodar
    F. Vasallo-Vidal
    L. Martinez-Lamas
    A. Pérez-Landeiro
    M. Rubianes
    MT. Pérez-Rodríguez
    European Journal of Clinical Microbiology & Infectious Diseases, 2022, 41 : 1173 - 1182
  • [24] Treatment of infections caused by carbapenemase-producing Enterobacterales
    Inigo, Melania
    Del Pozo, Jose Luis
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 46 - 50
  • [25] Susceptibility of carbapenemase-producing Enterobacterales (CPE) to nitroxoline
    Fuchs, Frieder
    Hamprecht, Axel
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (10) : 2934 - 2937
  • [26] Investigating Determinants of Pathogenicity of Carbapenemase-Producing Enterobacterales
    Temkin, Elizabeth
    Carmeli, Yehuda
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [27] Hospital effluent: A reservoir for carbapenemase-producing Enterobacterales?
    Cahill, Niamh
    O'Connor, Louise
    Mahon, Blathnaid
    Varley, Aine
    McGrath, Elaine
    Ryan, Phelim
    Cormican, Martin
    Brehony, Carina
    Jolley, Keith A.
    Maiden, Martin C.
    Brisse, Sylvain
    Morris, Dearbhsile
    SCIENCE OF THE TOTAL ENVIRONMENT, 2019, 672 : 618 - 624
  • [28] Carbapenemase-Producing Enterobacterales in Algeria: A Systematic Review
    Touati, Abdelaziz
    Mairi, Assia
    MICROBIAL DRUG RESISTANCE, 2020, 26 (05) : 475 - 482
  • [29] Ceftazidime/avibactam versus other antibiotics for the treatment of KPC carbapenemase-producing Enterobacterales bacteremia: real-life data from a university hospital in Argentina
    Herrera, Fabian
    Rearte, Andres Nicolas
    Mejia, Jairo Chevel
    Torres, Diego
    Nicola, Federico
    Nievas, Jimena
    Temporiti, Elena
    Bues, Florencia
    Leone, Maria Victoria
    Querci, Marcia
    Bonvehi, Pablo
    REVISTA CHILENA DE INFECTOLOGIA, 2023, 40 (06): : 589 - 598
  • [30] Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance
    Mushtaq, Shazad
    Vickers, Anna
    Woodford, Neil
    Livermore, David M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (03)
12345